Evidence map›Paper›PMID 24603431›Full record

ArticlePLoS genetics2014

Mitogen-activated protein kinase (MAPK) pathway regulates branching by remodeling epithelial cell adhesion.

Anneliis Ihermann-Hella, Maria Lume, Ilkka J Miinalainen, Anniina Pirttiniemi, Yujuan Gui, Johan Peränen, Jean Charron, Mart Saarma, Frank Costantini, Satu Kuure

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 77 citations in OpenAlex.

  1. CRISPR-Cas9 screening revealsMolecular therapy. Advances · 2026
    Article
  2. Testosterone Exposure During Fetal Masculinization Programming Window Determines the Kidney Size in Adult Mice.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Frontiers in medicine · 2021
    Article
  20. Frontiers in cell and developmental biology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Anneliis Ihermann-HellaInstitute of Biotechnology, University of Helsinki, Helsinki, Finland.
Maria LumeInstitute of Biotechnology, University of Helsinki, Helsinki, Finland.
Ilkka J MiinalainenDepartment of Pathology, University of Oulu, Oulu, Finland.
Anniina PirttiniemiInstitute of Biotechnology, University of Helsinki, Helsinki, Finland.
Yujuan GuiInstitute of Biotechnology, University of Helsinki, Helsinki, Finland.
Johan PeränenInstitute of Biotechnology, University of Helsinki, Helsinki, Finland.
Jean CharronCentre de Recherche en Cancérologie de l'Université Laval, CRCHUQ, Hôtel-Dieu de Québec, Québec, Canada.
Mart SaarmaInstitute of Biotechnology, University of Helsinki, Helsinki, Finland.
Frank CostantiniDepartment of Genetics and Development, Columbia University Medical Center, New York, New York, United States of America.
Satu KuureInstitute of Biotechnology, University of Helsinki, Helsinki, Finland.
University of Helsinki · FIColumbia University Irving Medical Center · USUniversité Laval · CAUniversity of Oulu · FI

Funding

Genetic Control of Ureter and Kidney DevelopmentR01DK082715 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI COSTANTINI, FRANKLIN D · 2009 to 2013
$3.1M
NIDDK NIH HHS 5R01DK082715NIDDK NIH HHS R01 DK082715
6 · The paper itself

Abstract

Although the growth factor (GF) signaling guiding renal branching is well characterized, the intracellular cascades mediating GF functions are poorly understood. We studied mitogen-activated protein kinase (MAPK) pathway specifically in the branching epithelia of developing kidney by genetically abrogating the pathway activity in mice lacking simultaneously dual-specificity protein kinases Mek1 and Mek2. Our data show that MAPK pathway is heterogeneously activated in the subset of G1- and S-phase epithelial cells, and its tissue-specific deletion results in severe renal hypodysplasia. Consequently to the deletion of Mek1/2, the activation of ERK1/2 in the epithelium is lost and normal branching pattern in mutant kidneys is substituted with elongation-only phenotype, in which the epithelium is largely unable to form novel branches and complex three-dimensional patterns, but able to grow without primary defects in mitosis. Cellular characterization of double mutant epithelium showed increased E-cadherin at the cell surfaces with its particular accumulation at baso-lateral locations. This indicates changes in cellular adhesion, which were revealed by electron microscopic analysis demonstrating intercellular gaps and increased extracellular space in double mutant epithelium. When challenged to form monolayer cultures, the mutant epithelial cells were impaired in spreading and displayed strong focal adhesions in addition to spiky E-cadherin. Inhibition of MAPK activity reduced paxillin phosphorylation on serine 83 while remnants of phospho-paxillin, together with another focal adhesion (FA) protein vinculin, were augmented at cell surface contacts. We show that MAPK activity is required for branching morphogenesis, and propose that it promotes cell cycle progression and higher cellular motility through remodeling of cellular adhesions.

Indexed as

AnimalsEpithelial CellsFocal AdhesionsKidneyMAP Kinase Kinase 1MAP Kinase Kinase 2MAP Kinase Signaling SystemMiceMitogen-Activated Protein KinasesMorphogenesisPhosphorylationSignal TransductionVinculinMap2k1 protein, mouseMap2k2 protein, mouseMAP Kinase Kinase 1MAP Kinase Kinase 2Mitogen-Activated Protein KinasesVinculin

Identifiers

PMID24603431
PMCPMC3945187
OpenAlexW1969522518

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.